News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...